Chemoinformaics analysis of 3-ACETYLOXY-4-(TRIMETHYLAZANIUMYL)BUTANOATE
| Molecular Weight | 203.238 | nRot | 5 |
| Heavy Atom Molecular Weight | 186.102 | nRig | 17 |
| Exact Molecular Weight | 203.116 | nRing | 0 |
| Solubility: LogS | -6.828 | nHRing | 0 |
| Solubility: LogP | 6.737 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 30.6735 |
| nHD | 0 | BPOL | 23.6745 |
| QED | 0.503 |
| Synth | 4.275 |
| Natural Product Likeliness | 3.393 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.266 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.683 |
| MDCK | 0.00001 |
| BBB | 0.338 |
| PPB | 0.978707 |
| VDSS | 2.78 |
| FU | 0.0299592 |
| CYP1A2-inh | 0.109 |
| CYP1A2-sub | 0.554 |
| CYP2c19-inh | 0.267 |
| CYP2c19-sub | 0.954 |
| CYP2c9-inh | 0.278 |
| CYP2c9-sub | 0.686 |
| CYP2d6-inh | 0.508 |
| CYP2d6-sub | 0.859 |
| CYP3a4-inh | 0.882 |
| CYP3a4-sub | 0.514 |
| CL | 4.165 |
| T12 | 0.022 |
| hERG | 0.004 |
| Ames | 0.015 |
| ROA | 0.056 |
| SkinSen | 0.044 |
| Carcinogencity | 0.203 |
| EI | 0.495 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.791 |
| Antiviral | No |
| Prediction | 0.930477 |